These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. RET gene mutations (genotype and phenotype) of multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Krampitz GW; Norton JA Cancer; 2014 Jul; 120(13):1920-31. PubMed ID: 24699901 [TBL] [Abstract][Full Text] [Related]
43. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients. Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712 [TBL] [Abstract][Full Text] [Related]
44. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325 [TBL] [Abstract][Full Text] [Related]
45. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606 [TBL] [Abstract][Full Text] [Related]
46. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)". Fink M; Weinhüsel A; Niederle B; Haas OA Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874 [TBL] [Abstract][Full Text] [Related]
48. Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Raue F; Frank-Raue K Hormones (Athens); 2009; 8(1):23-8. PubMed ID: 19269918 [TBL] [Abstract][Full Text] [Related]
49. [Hereditary thyroid cancer can be cured by prophylactic surgery]. Wallin G; Bondesson AG; Farnebo LO; Hallengren B; Hamberger B; Jansson S; Nilsson O; Nordenskjöld M; Smeds S; Svensson KA; Wihlborg O; Zedenius J Lakartidningen; 2001 Jun; 98(25):3024-8. PubMed ID: 11462876 [TBL] [Abstract][Full Text] [Related]
50. Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma. Chiefari E; Russo D; Giuffrida D; Zampa GA; Meringolo D; Arturi F; Chiodini I; Bianchi D; Attard M; Trischitta V; Bruno R; Giannasio P; Pontecorvi A; Filetti S J Endocrinol Invest; 1998 Jun; 21(6):358-64. PubMed ID: 9699127 [TBL] [Abstract][Full Text] [Related]
51. Emergence of medullary thyroid carcinoma in a family with the Cys630Arg RET germline mutation. Machens A; Schneyer U; Holzhausen HJ; Raue F; Dralle H Surgery; 2004 Nov; 136(5):1083-7. PubMed ID: 15523405 [TBL] [Abstract][Full Text] [Related]
52. Current management of medullary thyroid cancer. Sippel RS; Kunnimalaiyaan M; Chen H Oncologist; 2008 May; 13(5):539-47. PubMed ID: 18515739 [TBL] [Abstract][Full Text] [Related]
53. [Usefulness of the genetic study in the diagnosis of medullary carcinoma of the thyroid]. Rafecas A; Ribas Y; Villabona C; Viladrich M; Figueras J; Fabregat J; Torras J; Gómez JM; Jaurrieta E Med Clin (Barc); 1998 Nov; 111(16):619-22. PubMed ID: 9881336 [TBL] [Abstract][Full Text] [Related]
54. [Medullary thyroid carcinoma and some of its particularities]. Sidibé el H Sante; 2007; 17(1):51-5. PubMed ID: 17897902 [TBL] [Abstract][Full Text] [Related]
55. Change in the spectrum of RET mutations diagnosed between 1994 and 2006. Frank-Raue K; Rondot S; Schulze E; Raue F Clin Lab; 2007; 53(5-6):273-82. PubMed ID: 17605401 [TBL] [Abstract][Full Text] [Related]
56. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family]. Benazzouz B; Hafidi A; Benkhira S; Chraibi A; Kadiri A; Hilal L Bull Cancer; 2008 Apr; 95(4):457-63. PubMed ID: 18495576 [TBL] [Abstract][Full Text] [Related]
57. A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening. Kaldrymides P; Mytakidis N; Anagnostopoulos T; Vassiliou M; Tertipi A; Zahariou M; Rampias T; Koutsodontis G; Konstantopoulou I; Ladopoulou A; Bei T; Yannoukakos D Clin Endocrinol (Oxf); 2006 May; 64(5):561-6. PubMed ID: 16649977 [TBL] [Abstract][Full Text] [Related]
58. Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation. González-Yebra B; Medrano ME; Mantilla A; Palma V; Colin C; Hernández DM; Tapia J; Dawson B; Salcedo M Endocr Pathol; 2003; 14(1):71-80. PubMed ID: 12746565 [TBL] [Abstract][Full Text] [Related]
59. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside. Machens A; Dralle H Mol Cell Endocrinol; 2006 Mar; 247(1-2):34-40. PubMed ID: 16343738 [TBL] [Abstract][Full Text] [Related]